摘要
目的:回顾性分析钻孔减压联合药物髓内注射治疗早期非创伤性股骨头坏死的近期疗效。方法:选取2013年9月—2014年7月于我院就诊并诊断为早期非创伤性股骨头坏死(FicatⅠ期、Ⅱ期)患者38例(42髋),采用经股骨大转子钻孔减压联合复方骨肽及丹参川芎嗪注射液髓内注射治疗,每周注射l次,连续注射4次为一疗程。休息2月后再进行下一疗程,共治疗3个疗程(9月)。结果:随访时间6~15月,优l8髋(42.9%),良l3髋(30.9%),可9髋(21.4%),差2髋(4.8%)。结论:钻孔减压联合药物髓内注射治疗早期非创伤性股骨头坏死的近期疗效显著,但远期疗效尚需进一步观察。
Objective : To analyze the recent curative effect of drilling core decompression combined with medicine intraosseous injection in the treatment of early non - traumatic necrosis of femoral head retrospectively. Methods:38 patients(42hips) from September of 2013 to July of 2014,the Affiliated Hospital of Chengdu University of TCM and diagnosed as early non - traumatic necrosis of femoral head (Ficat Phase 1 and Phase II) , treats from Percutaneous large trochanter of femur with drilling core decompression combined with com-pound ossotide and Danshen Chuanxiongqin injection, once a week,4 times in a row for each period of treatment and then have a rest for 2 months before the next course of treatment,3 periods of treatment in all(9 months). Results: Follow - up was performed for 6 - 15months, excellent 18 hips(42.9% ) ,good 13 hips( 3 0 .9% ) , basically qualified 9 hips( 2 1 .4% ) , poor 2 hips(4. 8% ) . Conclusion: the recent curative effect of drilling core decompression combined with medicine intraosseous injection is remarkable, so it is worthy of popularizing,but the long - term effect still needs a further observation.
出处
《江西中医药大学学报》
2017年第4期38-40,共3页
Journal of Jiangxi University of Chinese Medicine
关键词
股骨头坏死
钻孔减压
髓内注射
复方骨肽
丹参川芎嗪注射液
Non - traumatic Necrosis of Femoral Head
Drilling Core Decompression
Intraosseous Injection
Compound Bone Peptide
Danshen Chuanxiongqin injection